Pricing Log in Create free account

Lakefront Biotherapeutics - Sponsored ADR (LKFT) vs Zymeworks Inc. (ZYME)

Lakefront Biotherapeutics - Sponsored ADR and Zymeworks Inc. are both Biotechnology companies. Lakefront Biotherapeutics - Sponsored ADR and Zymeworks Inc. are of similar size ($2.2B and $2.0B). Lakefront Biotherapeutics - Sponsored ADR grew revenue faster over the last twelve months: −52.2% against −69.8%. Lakefront Biotherapeutics - Sponsored ADR has the higher net margin (−6.81% vs −404.0%) and the higher return on invested capital (0.00% vs 0.00%). Across the 17 metrics below, Lakefront Biotherapeutics - Sponsored ADR leads on 14 and Zymeworks Inc. on 3.

Valuation

Metric LKFT ZYME Biotechnology median
P/E n/m n/m 10.26
P/S 7.87 56.80 9.18
P/B 0.58 26.24 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA 0.91 n/m 0.65
EV/Sales (1.35) 49.52 8.98
Earnings yield (0.85%) (6.99%) (34.89%)
Free cash flow yield (26.89%) (5.76%) (24.52%)

Profitability

Metric LKFT ZYME Biotechnology median
Gross margin 89.75% (246.66%) 65.16%
Operating margin (90.11%) (418.99%) 0.00%
Net margin (6.81%) (404.00%) 0.00%
Free cash flow margin 0.00% (324.68%) 0.00%
Return on equity 0.00% (72.31%) (50.12%)
Return on assets 0.00% (37.25%) (45.60%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric LKFT ZYME Biotechnology median
Revenue growth (TTM) (52.22%) (69.78%) 6.26%
EPS growth (last fiscal year) 355.37% 33.33% 29.88%
Revenue growth, 5-year CAGR 15.75% 22.16% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric LKFT ZYME Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 32.84 6.32 4.89
Net debt to EBITDA (8.53) 2.81 1.01

Dividend

Metric LKFT ZYME Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric LKFT ZYME Biotechnology median
Market cap 2.20b 2.04b 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack